Infectious Diseases Clinical Trial
Official title:
Nuclear Medicine for the Evaluation of Infection-the Added Value of Hybrid Imaging Modalities
The synergistic value of the fusion of physiologic and anatomical data has been described
using several co-registration techniques for various nuclear medicine procedures and
morphologic imaging modalities (single photon emission computed tomography-computed
tomography [SPECT-CT], SPECT-magnetic resonance imaging [MRI], camera-based positron
emission tomography [PET]-CT and PET-CT). The researchers hypothesize that fusion of nuclear
medicine (NM) and CT data acquired sequentially in a single imaging session on one device is
clinically superior to side-by-side evaluation of separately performed imaging tests. They
hypothesize that more accurate localization of increased radiotracer activity on NM
procedures will improve the diagnostic accuracy for detection of infection and will
subsequently have a significant impact on patient management.
The purpose of the present study is to assess the clinical value of this new technology of
fused imaging in patients undergoing diagnostic nuclear medicine evaluation for suspicion of
an infection process.
The researchers hypothesize that fusion of nuclear medicine (NM) and CT data acquired
sequentially in a single imaging session on one device is clinically superior to
side-by-side evaluation of separately performed imaging tests. They hypothesize that more
accurate localization of increased radiotracer activity on NM procedures will improve the
diagnostic accuracy for detection of infection and will subsequently have a significant
impact on patient management.
The purpose of the present study is to assess the clinical value of this new technology of
fused imaging in patients undergoing diagnostic nuclear medicine evaluation for suspicion of
an infection process.
;
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02763345 -
The Added Value of a Mobile Application of Community Case Management on Pediatric Referral Rates in Malawi
|
N/A | |
Completed |
NCT00550706 -
Drug Utilization Prevalence in a Pediatric Care Medical Center
|
N/A | |
Completed |
NCT01033799 -
Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers
|
N/A | |
Completed |
NCT00761462 -
BAY 0 9867 Cipro Pediatric Use Study (QUIP)
|
Phase 3 | |
Completed |
NCT05088421 -
A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00828971 -
A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs
|
Phase 3 | |
Completed |
NCT05468723 -
Evaluating Patient Comfort and Environmental Conditions in the Carecube Negative Pressure Isolation Chamber.1
|
||
Recruiting |
NCT02162966 -
Safety and Efficacy Study of High Dose Colistin
|
Phase 4 | |
Recruiting |
NCT00001281 -
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
|
||
Active, not recruiting |
NCT02654210 -
LoewenKIDS - Infections and the Development of the Immune System
|
||
Completed |
NCT02226263 -
Severe Necrotizing Enterocolitis in Preterm Newborns <1500g Using Probiotics
|
Phase 2 | |
Terminated |
NCT00211471 -
Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
|
Phase 2 | |
Active, not recruiting |
NCT04342702 -
A Study on the Prospective Cohort Library of COVID-19 in Southeran
|
||
Completed |
NCT02134548 -
Sensitivity Study of Diagnostic for Detection of Chagas Infection
|
N/A | |
Active, not recruiting |
NCT01611025 -
Hospital Microbial Ecology Follow the Introduction of Ertapenem and Other Newly Introduced Antibiotic Over Time
|
N/A | |
Completed |
NCT01361997 -
Isopropyl Alcohol Against Chlorhexidine - Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contamination
|
Phase 3 | |
Completed |
NCT00638677 -
Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier
|
Phase 4 | |
Completed |
NCT02434848 -
A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses
|
Phase 2/Phase 3 | |
Completed |
NCT02544139 -
Specificity Study of Diagnostic for Chagas Disease
|
N/A | |
Completed |
NCT00276198 -
Efficacy Trial to Examine Efficacy of Multimicronutrient Home Supplementation in Infants
|
Phase 3 |